Connecting the world to precision oncology, from insight to action.

Oncomine Next-Generation Sequencing Solutions for Genomic Profiling

Advancing Discoveries. Expanding Access.

We provide simple and rapid next-generation sequencing (NGS) solutions for oncology research and routine patient testing.
Our customers are accelerating clinical discoveries and bringing precision oncology care to more patients, everywhere.

Learn about NGS in Precision Oncology

Explore our Education Center to learn how NGS for solid tumor and hemato-oncology empowers researchers and clinicians to leverage advanced genomic profiling techniques to identify genetic alterations, biomarkers, and potential therapeutic targets, ultimately helping to improve patient outcomes and advancing precision medicine in cancer care.

New to NGS?

Download our Introduction to NGS for Precision Oncology Guide and learn
how NGS improves patient outcomes, key applications and how easy it is to bring NGS to your lab.



Oncomine Solutions for clinical research

Oncomine Solutions offer end-to-end  NGS workflows that enable faster results for oncology research.

Oncomine Solutions for in vitro diagnostics

Oncomine IVD (In Vitro Diagnostic) is a comprehensive oncology testing solution that offers a range of services for the molecular profiling of cancer patients.

It is designed to provide oncologists and pathologists with valuable insights into the genetic alterations present in tumors, ultimately aiding in the selection of appropriate targeted therapies for patients.

Oncomine IVD Solutions

Our IVD solutions enable fast NGS testing for clinically relevant biomarkers in as little as 24 hours. This specimen-to-report workflow is easy to implement and operate with minimal hands-on time.

> Explore IVD Solutions



Featured Event

OncomineWorld 2024: A virtual NGS education meeting is now on demand!

New on-demand presentations are now available. Since 2020, OncomineWorld virtual meetings have brought together thousands of scientists and professionals from around the world each year to advance genomic profiling in clinical oncology research. Attend any of our sessions on demand to enjoy presentations that explore the utility of next-generation sequencing for a variety of oncology research applications, including a new approach to homologous recombination deficiency (HRD) assessment: the genomic instability metric (GIM).

> Register Now




Join our Oncomine Community

The Oncomine Solutions Community is a global network dedicated to advancing precision oncology research. As a member of this community, you have access to exclusive educational content, first-class support, grant opportunities and more. 

> Learn more about the Oncomine Community

Have questions?  We look forward to speaking with you about bringing NGS to your lab.


Subscribe here to stay abreast of the latest news about NGS in precision oncology.